THE EFFICACY OF COMBINED NEUROPROTECTION IN MOTOR AND COGNITIVE RECOVERY FOLLOWING THE ACUTE PHASE OF ISCHEMIC STROKE
https://doi.org/10.29001/2073-8552-2018-33-4-131-135
Abstract
The clinical efficacy of combined neuroprotection with citicoline and cortexin in the acute period of ischemic stroke is discussed in the paper. A retrospective analysis of 127 cases with a primary ischemic stroke was carried out. For unbiased evaluation of the severity of the condition, extent of the focal neurological deficit and the assessment of the dynamics in clinical indicators, the National Institute of Health Stroke Scale was used; the degree of functional recovery was assessed by the modified Rankin Scale; the cognitive status score was measured by the MMSE scale. The obtained data suggest the effectiveness of combined neuroprotection with cortexin and citicoline in the acute period of ischemic stroke in comparison with monotherapy.
About the Authors
A. E. Shoboev
Buryat State University, Medical Institute
Russian Federation
Russian Federation
Research Assistant, Department of Pharmacology and Traditional Medicine
36, Oktyabrskaya str., Ulan-Ude, 670002, Russian Federation
I. M. Balkhayev
Buryat State University, Medical Institute
Russian Federation
Russian Federation
Dr. Sci. (Med.), Associate Professor, Department of Pharmacology and Traditional Medicine
36, Oktyabrskaya str., Ulan-Ude, 670002, Russian Federation
References
1. AHA/ASA Guideline. Primary Prevention of Ischemic Stroke. Stroke. 2006; 37(6): 1583–1633.
2. Hackam G., David J. Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke. A Quantitative Modeling Study. Stroke. 2007; 38(6): 1881–1885.
3. Guidelines for Prevention of Stroke in Patients with Ischemic Stroke or Transient Ischemic Attack. Stroke. 2006; 37(2): 577–617.
4. Vereshchagin N. V. Insufficiency of blood circulation in vertebro-basilar system. Consilium Medicum, Journal of Evidence-Based Medicine for Practitioners. 2003; 5(2): 56–61 (In Russ.).
5. Gomazkov O. A. Cortexin: molecular mechanisms and targets of neuroprotective activity. Journal of Neurology and Psychiatry. 2015; 8: 99–104 (In Russ.).
6. Stroke: diagnosis, treatment, prevention. Ed. by Z. A. Suslina, M. A. Piradov. Мoscow: MEDpress-inform, 2008: 288 (In Russ.).
7. Piradov M. A., Sergeev D. V., Krotenkova M. V. The use of Ceraxon in the acute period of hemispheric ischemic stroke: clinical and CT perfusion evaluation. Annals of Clinical and Experimental Neurology. 2012; 6(3): 31–35 (In Russ.).
8. Saver J. L., Wilterdink J. Choline precursors in acute and subacute human stroke: a meta-analysis. Stroke. 2002; 33: 353.
9. Skoromets A. A. New possibilities of neuroprotection in the treatment of ischemic stroke. Insult. 2008; 22: 32–38 (In Russ.).
Review
For citations:
Shoboev A.E., Balkhayev I.M. THE EFFICACY OF COMBINED NEUROPROTECTION IN MOTOR AND COGNITIVE RECOVERY FOLLOWING THE ACUTE PHASE OF ISCHEMIC STROKE. Siberian Journal of Clinical and Experimental Medicine. 2018;33(4):131-135. (In Russ.) https://doi.org/10.29001/2073-8552-2018-33-4-131-135
Views:
601
.png)
Email this article 